172 related articles for article (PubMed ID: 7641217)
1. Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patients.
Uttenreuther-Fischer MM; Huang CS; Reisfeld RA; Yu AL
Cancer Immunol Immunother; 1995 Jul; 41(1):29-36. PubMed ID: 7641217
[TBL] [Abstract][Full Text] [Related]
2. Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.
Murray JL; Cunningham JE; Brewer H; Mujoo K; Zukiwski AA; Podoloff DA; Kasi LP; Bhadkamkar V; Fritsche HA; Benjamin RS
J Clin Oncol; 1994 Jan; 12(1):184-93. PubMed ID: 8270976
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients.
Uttenreuther-Fischer MM; Huang CS; Yu AL
Cancer Immunol Immunother; 1995 Dec; 41(6):331-8. PubMed ID: 8635190
[TBL] [Abstract][Full Text] [Related]
4. Endothelin A receptor antagonism enhances inhibitory effects of anti-ganglioside GD2 monoclonal antibody on invasiveness and viability of human osteosarcoma cells.
Liu B; Wu Y; Zhou Y; Peng D
PLoS One; 2014; 9(4):e93576. PubMed ID: 24727660
[TBL] [Abstract][Full Text] [Related]
5. Analysis and optimization of interactions between peptides mimicking the GD2 ganglioside and the monoclonal antibody 14G2a.
Horwacik I; Kurciński M; Bzowska M; Kowalczyk AK; Czaplicki D; Koliński A; Rokita H
Int J Mol Med; 2011 Jul; 28(1):47-57. PubMed ID: 21455557
[TBL] [Abstract][Full Text] [Related]
6. Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.
Horwacik I; Rokita H
Int J Oncol; 2017 May; 50(5):1899-1914. PubMed ID: 28393238
[TBL] [Abstract][Full Text] [Related]
7. Anti-ganglioside GD2 monoclonal antibody synergizes with cisplatin to induce endoplasmic reticulum-associated apoptosis in osteosarcoma cells.
Zhu W; Mao X; Wang W; Chen Y; Li D; Li H; Dou P
Pharmazie; 2018 Feb; 73(2):80-86. PubMed ID: 29442009
[TBL] [Abstract][Full Text] [Related]
8. The GD2-specific 14G2a monoclonal antibody induces apoptosis and enhances cytotoxicity of chemotherapeutic drugs in IMR-32 human neuroblastoma cells.
Kowalczyk A; Gil M; Horwacik I; Odrowaz Z; Kozbor D; Rokita H
Cancer Lett; 2009 Aug; 281(2):171-82. PubMed ID: 19339105
[TBL] [Abstract][Full Text] [Related]
9. GD2 ganglioside-binding antibody 14G2a and specific aurora A kinase inhibitor MK-5108 induce autophagy in IMR-32 neuroblastoma cells.
Durbas M; Pabisz P; Wawak K; Wiśniewska A; Boratyn E; Nowak I; Horwacik I; Woźnicka O; Rokita H
Apoptosis; 2018 Oct; 23(9-10):492-511. PubMed ID: 30027525
[TBL] [Abstract][Full Text] [Related]
10. Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.
Yu AL; Uttenreuther-Fischer MM; Huang CS; Tsui CC; Gillies SD; Reisfeld RA; Kung FH
J Clin Oncol; 1998 Jun; 16(6):2169-80. PubMed ID: 9626218
[TBL] [Abstract][Full Text] [Related]
11. Analysis of genes involved in response to doxorubicin and a GD2 ganglioside-specific 14G2a monoclonal antibody in IMR-32 human neuroblastoma cells.
Horwacik I; Durbas M; Boratyn E; Sawicka A; Węgrzyn P; Krzanik S; Górka A; Drożniak J; Augustyniak E; Kowalczyk A; Rokita H
Acta Biochim Pol; 2015; 62(3):423-33. PubMed ID: 26284262
[TBL] [Abstract][Full Text] [Related]
12. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Bolesta E; Kowalczyk A; Wierzbicki A; Rotkiewicz P; Bambach B; Tsao CY; Horwacik I; Kolinski A; Rokita H; Brecher M; Wang X; Ferrone S; Kozbor D
Cancer Res; 2005 Apr; 65(8):3410-8. PubMed ID: 15833876
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma.
Saleh MN; Khazaeli MB; Wheeler RH; Dropcho E; Liu T; Urist M; Miller DM; Lawson S; Dixon P; Russell CH
Cancer Res; 1992 Aug; 52(16):4342-7. PubMed ID: 1643631
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a mimotope of GD2 ganglioside induces CD8+ T cells that recognize cell adhesion molecules on tumor cells.
Wierzbicki A; Gil M; Ciesielski M; Fenstermaker RA; Kaneko Y; Rokita H; Lau JT; Kozbor D
J Immunol; 2008 Nov; 181(9):6644-53. PubMed ID: 18941255
[TBL] [Abstract][Full Text] [Related]
16. GD2 ganglioside specific antibody treatment downregulates PI3K/Akt/mTOR signaling network in human neuroblastoma cell lines.
Durbas M; Horwacik I; Boratyn E; Kamycka E; Rokita H
Int J Oncol; 2015 Sep; 47(3):1143-59. PubMed ID: 26134970
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity.
Alvarez-Rueda N; Desselle A; Cochonneau D; Chaumette T; Clemenceau B; Leprieur S; Bougras G; Supiot S; Mussini JM; Barbet J; Saba J; Paris F; Aubry J; Birklé S
PLoS One; 2011; 6(9):e25220. PubMed ID: 21966461
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human anti-idiotypic antibody that mimics the GD2 antigen.
Saleh MN; Stapleton JD; Khazaeli MB; LoBuglio AF
J Immunol; 1993 Sep; 151(6):3390-8. PubMed ID: 8376782
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a.
Handgretinger R; Baader P; Dopfer R; Klingebiel T; Reuland P; Treuner J; Reisfeld RA; Niethammer D
Cancer Immunol Immunother; 1992; 35(3):199-204. PubMed ID: 1638557
[TBL] [Abstract][Full Text] [Related]
20. Targeting GD2 ganglioside and aurora A kinase as a dual strategy leading to cell death in cultures of human neuroblastoma cells.
Horwacik I; Durbas M; Boratyn E; Węgrzyn P; Rokita H
Cancer Lett; 2013 Dec; 341(2):248-64. PubMed ID: 23962557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]